EP3723735A4 - Tolperison und nicht-selektive cox-inhibitorkombinationen - Google Patents

Tolperison und nicht-selektive cox-inhibitorkombinationen Download PDF

Info

Publication number
EP3723735A4
EP3723735A4 EP18911384.8A EP18911384A EP3723735A4 EP 3723735 A4 EP3723735 A4 EP 3723735A4 EP 18911384 A EP18911384 A EP 18911384A EP 3723735 A4 EP3723735 A4 EP 3723735A4
Authority
EP
European Patent Office
Prior art keywords
tolperisone
combinations
selective cox
cox inhibitor
inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP18911384.8A
Other languages
English (en)
French (fr)
Other versions
EP3723735A2 (de
Inventor
Ali TÜRKYILMAZ
Nur PEHLIVAN AKALIN
Seyhan TÜRKKAN
Melda MISIRLI
Emine TUNCAY
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanovel Ilac Sanayi ve Ticaret AS
Original Assignee
Sanovel Ilac Sanayi ve Ticaret AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi ve Ticaret AS filed Critical Sanovel Ilac Sanayi ve Ticaret AS
Publication of EP3723735A2 publication Critical patent/EP3723735A2/de
Publication of EP3723735A4 publication Critical patent/EP3723735A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
EP18911384.8A 2017-12-13 2018-12-12 Tolperison und nicht-selektive cox-inhibitorkombinationen Withdrawn EP3723735A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2017/20293A TR201720293A2 (tr) 2017-12-13 2017-12-13 Tolperi̇zon ve non-selekti̇f cox i̇nhi̇bi̇törü kombi̇nasyonlari
PCT/TR2018/050801 WO2019190432A2 (en) 2017-12-13 2018-12-12 Tolperisone and non-selective cox inhibitor combinations

Publications (2)

Publication Number Publication Date
EP3723735A2 EP3723735A2 (de) 2020-10-21
EP3723735A4 true EP3723735A4 (de) 2021-11-10

Family

ID=67952207

Family Applications (1)

Application Number Title Priority Date Filing Date
EP18911384.8A Withdrawn EP3723735A4 (de) 2017-12-13 2018-12-12 Tolperison und nicht-selektive cox-inhibitorkombinationen

Country Status (3)

Country Link
EP (1) EP3723735A4 (de)
TR (1) TR201720293A2 (de)
WO (1) WO2019190432A2 (de)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1362585A2 (de) * 2001-01-26 2003-11-19 Osmotica Corp. Pharmazeutische zusammensetzungen mit einem cox-ii-hemmer und einem muskelrelaxans
WO2009081217A1 (en) * 2007-12-20 2009-07-02 Richter Gedeon Nyrt. Pharmaceutical formulations containing tolperisone
WO2010103544A2 (en) * 2009-03-09 2010-09-16 Dinesh Shantilal Patel A novel sustained release composition of compounds selected from the class of centrally acting muscle relaxants

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1362585A2 (de) * 2001-01-26 2003-11-19 Osmotica Corp. Pharmazeutische zusammensetzungen mit einem cox-ii-hemmer und einem muskelrelaxans
WO2009081217A1 (en) * 2007-12-20 2009-07-02 Richter Gedeon Nyrt. Pharmaceutical formulations containing tolperisone
WO2010103544A2 (en) * 2009-03-09 2010-09-16 Dinesh Shantilal Patel A novel sustained release composition of compounds selected from the class of centrally acting muscle relaxants

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2019190432A2 *

Also Published As

Publication number Publication date
WO2019190432A2 (en) 2019-10-03
TR201720293A2 (tr) 2019-06-21
WO2019190432A3 (en) 2019-11-21
EP3723735A2 (de) 2020-10-21

Similar Documents

Publication Publication Date Title
MA44725A (fr) Formulations d'un inhibiteur de lsd1
EP3743525A4 (de) Näherungsdetektionsverfahren und -zusammensetzungen
IL283782A (en) Anellosomes and methods of use
MA52004A (fr) Inhibiteurs d'o-glycoprotéine-2-acétamido-2-désoxy-3-d-glycopyranosidase
MA49006A (fr) Inhibiteurs d'ip6k
HUE063120T2 (hu) LRRC33-inhibitorok és alkalmazásuk
EP3844500A4 (de) Rp182-zusammensetzungen und verfahren
EP3415524A4 (de) INHIBITOR DER a-SYNUKLEIN-EXPRESSION
MA53648A (fr) Inhibiteurs d'o-glycoprotéine-2-acétamido-2-désoxy-3-d-glucopyranosidase
EP4017857A4 (de) Mettl16-inhibitoren und verwendungen davon
EP3778119A4 (de) Abrichtgerät
EP4065112A4 (de) Taspase1-inhibitoren und verwendungen davon
EP3723735A4 (de) Tolperison und nicht-selektive cox-inhibitorkombinationen
EP4038072A4 (de) Mcl1-inhibitoren und verwendungen davon
UA39602S (uk) Комплект етикеток
EP3829872A4 (de) Abdeckmarkierung
UA39416S (uk) Комплект етикеток
UA38480S (uk) Комплект етикеток
UA37658S (uk) Комплект етикеток
UA38442S (uk) Комплект етикеток
UA39909S (uk) Комплект етикеток
UA37616S (uk) Комплект етикеток
UA37610S (uk) Комплект етикеток
UA39768S (uk) Комплект етикеток
UA36610S (uk) Комплект етикеток

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20200710

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20211011

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/28 20060101ALI20211005BHEP

Ipc: A61K 31/192 20060101ALI20211005BHEP

Ipc: A61K 31/4453 20060101ALI20211005BHEP

Ipc: A61K 9/20 20060101AFI20211005BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20230701